BIO Stock Overview
Engages in the development, commercialization, and marketing of various live biotherapeutics and complimentary medicines in Australia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Biome Australia Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.56 |
| 52 Week High | AU$0.87 |
| 52 Week Low | AU$0.14 |
| Beta | 1.34 |
| 11 Month Change | -29.56% |
| 3 Month Change | -17.04% |
| 1 Year Change | 300.00% |
| 33 Year Change | 409.09% |
| 5 Year Change | n/a |
| Change since IPO | 366.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIO | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | -1.8% | 1.8% | 0.5% |
| 1Y | 300.0% | 61.3% | 17.4% |
Return vs Industry: BIO exceeded the Australian Personal Products industry which returned 61.3% over the past year.
Return vs Market: BIO exceeded the Australian Market which returned 17.4% over the past year.
Price Volatility
| BIO volatility | |
|---|---|
| BIO Average Weekly Movement | 10.5% |
| Personal Products Industry Average Movement | 5.7% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in AU Market | 17.0% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: BIO has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: BIO's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 30 | Blair William Brabin Norfolk | www.biomeaustralia.com |
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complimentary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and organic nutraceutical products under the Activated Nutrients brand. It markets its products through community pharmacies, independent health practitioners, and health professionals.
Biome Australia Limited Fundamentals Summary
| BIO fundamental statistics | |
|---|---|
| Market cap | AU$119.42m |
| Earnings (TTM) | -AU$1.67m |
| Revenue (TTM) | AU$13.01m |
9.4x
P/S Ratio-73.5x
P/E RatioIs BIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIO income statement (TTM) | |
|---|---|
| Revenue | AU$13.01m |
| Cost of Revenue | AU$5.10m |
| Gross Profit | AU$7.91m |
| Other Expenses | AU$9.58m |
| Earnings | -AU$1.67m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0076 |
| Gross Margin | 60.81% |
| Net Profit Margin | -12.84% |
| Debt/Equity Ratio | 35.2% |
How did BIO perform over the long term?
See historical performance and comparison